SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    M. Carmen Martínez-Jiménez, Patricia Muñoz, Maricela Valerio, Antonio Vena, Jesús Guinea, Emilio Bouza, Combination ofCandidabiomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment, Journal of Antimicrobial Chemotherapy, 2015, 70, 11, 3107

    CrossRef

  2. 2
    H. Hammarström, N. Kondori, V. Friman, C. Wennerås, How to interpret serum levels of beta-glucan for the diagnosis of invasive fungal infections in adult high-risk hematology patients: optimal cut-off levels and confounding factors, European Journal of Clinical Microbiology & Infectious Diseases, 2015, 34, 5, 917

    CrossRef

  3. 3
    Małgorzata Mikulska, Elisa Furfaro, Claudio Viscoli, Non-cultural methods for the diagnosis of invasive fungal disease, Expert Review of Anti-infective Therapy, 2015, 13, 1, 103

    CrossRef

  4. 4
    Elisa Furfaro, Claudio Viscoli, Daniele Roberto Giacobbe, Sandra Ratto, Malgorzata Mikulska, The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis, Current Fungal Infection Reports, 2015, 9, 4, 292

    CrossRef

  5. 5
    Estrella Martín-Mazuelos, Ana Loza, Carmen Castro, Desirée Macías, Ismail Zakariya, Pedro Saavedra, Sergio Ruiz-Santana, Elena Marín, Cristóbal León, β-d-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis, Intensive Care Medicine, 2015, 41, 8, 1424

    CrossRef

  6. 6
    Marwan M. Azar, Joshua Malo, Kenneth S. Knox, Chadi A. Hage, Pulmonary fungal infections- recent updates, Current Respiratory Care Reports, 2014, 3, 4, 150

    CrossRef

  7. 7
    Eric P. Richards, Shahrzad Mohammadi, Graeme N. Forrest, 1–3 β-D-glucan: From Diagnosis to Prognosis, Current Fungal Infection Reports, 2013, 7, 1, 15

    CrossRef